|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1986-4-18
|
|
pubmed:abstractText |
Epstein-Barr virus-transformed human B cells expressed cell surface varicella-zoster virus (VZV) antigens after superinfection with VZV although they did not form infectious centers in a plaque assay. The VZV-superinfected cells were lysed by autologous VZV-stimulated T-cell lines and their derivative clones. The effector cells were specific for VZV and an HLA DR antigen and were T4+. The specificity of lysis of Epstein-Barr virus-transformed, VZV-superinfected targets by prestimulated mononuclear cells in this system contrasted with the unrestricted lysis seen when the targets were VZV-infected fibroblasts.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-233982,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-2580908,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-2993665,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-4346033,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6163722,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6189945,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6190908,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6203977,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6207243,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6247671,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6273741,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6327319,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6327848,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-6490855,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-78901,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3005647-87425
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-538X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
179-84
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:3005647-Antigens, Viral,
pubmed-meshheading:3005647-B-Lymphocytes,
pubmed-meshheading:3005647-Cell Line,
pubmed-meshheading:3005647-Cell Transformation, Viral,
pubmed-meshheading:3005647-Clone Cells,
pubmed-meshheading:3005647-Cytotoxicity, Immunologic,
pubmed-meshheading:3005647-Dose-Response Relationship, Immunologic,
pubmed-meshheading:3005647-Herpesvirus 3, Human,
pubmed-meshheading:3005647-Herpesvirus 4, Human,
pubmed-meshheading:3005647-Humans,
pubmed-meshheading:3005647-Immunity, Cellular,
pubmed-meshheading:3005647-T-Lymphocytes
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
